MedTrace Logo

Enhanced TB Screening to Determine the Prevalence and Incidence of TB in Patients With HIV

NCT02043067 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2017-09-15

No results posted yet for this study

Summary

This study will examine an enhanced protocol to systematically screen a cohort of 400 new HIV clinic enrollees for prevalence and 1-year incidence of tuberculosis (TB).

Conditions

Interventions

OTHER

Comprehensive TB screening

All enrollees will receive a comprehensive TB screening regardless of symptom presentation.

Sponsors & Collaborators

Principal Investigators

  • Stewart Reid, MD · CIDRZ; University of North Carolina at Chapel Hill

Eligibility

Min Age
16 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-10-31
Primary Completion
2012-09-30
Completion
2013-05-31

Countries

  • Zambia

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02043067 on ClinicalTrials.gov